Curium is the world’s leader in radiopharmaceuticals with more than a century of industry experience. Curium specializes in the development, production and distribution of SPECT, PET and therapeutic radiopharmaceuticals products to help patients around the globe. By potentially enabling accurate early diagnosis and treatment of cancer, as well as heart, brain and bone diseases, Curium’s world-class products empower customers with effective treatment, and proven patient outcomes.
Curium’s unrivaled logistics and distribution network makes it possible to serve 6000+ global customer-base in more than 70 countries with outstanding reliability and superior service. Crucially, this means diverse portfolio of more than 50 radiopharmaceutical products is helping to improve the lives of 14 million patients each year. Curium has one of the largest vertically integrated radiopharmaceutical manufacturing networks in the industry. This includes: 1 Molybdenum facility, 3 large SPECT facilities and close to 40 PET & SPECT radiopharmacies across North America and Europe.
Our core values—integrity, commitment and collaboration—drive every aspect of our behavior. It is our dedication to these values that truly sets us apart from the competition.

Curium is the world’s leader in radiopharmaceuticals with more than a century of industry experience. Curium specializes in the development, production and distribution of SPECT, PET and therapeutic radiopharmaceuticals products to help patients around the globe. By potentially enabling accurate early diagnosis and treatment of cancer, as well as heart, brain and bone diseases, Curium’s world-class products empower customers with effective treatment, and proven patient outcomes. Curium’s unrivaled logistics and distribution network makes it possible to serve 6000+ global customer-base in more than 70 countries with outstanding reliability and superior service. Crucially, this means diverse portfolio of more than 50 radiopharmaceutical products is helping to improve the lives of 14 million patients each year. Curium has one of the largest vertically integrated radiopharmaceutical manufacturing networks in the industry. This includes: 1 Molybdenum facility, 3 large SPECT facilities and close to 40 PET & SPECT radiopharmacies across North America and Europe. Our core values—integrity, commitment and collaboration—drive every aspect of our behavior. It is our dedication to these values that truly sets us apart from the competition.